Logo

S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

  1. Institute of Rheumatology, Prague, Czech Republic.
  2. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  3. Institute of Rheumatology, Prague, Czech Republic.
  4. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  5. Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  6. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  7. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  8. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  9. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  10. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  11. Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. senolt@revma.cz

CER11371 Submission on line
2019 Vol.37, N°2 - PI 0338, PF 0339
Letter

Free to view (click on article PDF icon to read the article)

Rheumatology Article

 

PMID: 30719969 [PubMed]

Received: 02/05/2018 - Accepted : 31/08/2018 - In Press: 04/02/2019 - Published: 19/03/2019